...
首页> 外文期刊>Clinical and Translational Oncology >Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy
【24h】

Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy

机译:血浆D-二聚体在接受一线化疗的晚期非小细胞肺癌患者中的预后和预测价值

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose Previous studies have demonstrated that plasma D-dimer, a degradation product of cross-linked fibrin, correlated with tumor stage and prognosis in cancer patients. The aim of this study is to examine whether plasma D-dimer levels before and during chemotherapy predict tumor response and survival in advanced NSCLC patients undergoing first line chemotherapy.
机译:目的先前的研究表明,血浆D-二聚体(一种交联纤维蛋白的降解产物)与癌症患者的肿瘤分期和预后相关。这项研究的目的是检查化疗前和化疗期间血浆D-二聚体水平是否可预测接受一线化疗的晚期NSCLC患者的肿瘤反应和生存率。

著录项

  • 来源
    《Clinical and Translational Oncology》 |2015年第1期|57-64|共8页
  • 作者单位

    Department of Pulmonary Medicine Affiliated Hospital of Jiangsu University">(1);

    Department of Pulmonary Medicine Affiliated Hospital of Jiangsu University">(1);

    Department of Pulmonary Medicine Affiliated Hospital of Jiangsu University">(1);

    Department of Pulmonary Medicine Affiliated Hospital of Jiangsu University">(1);

    Center of Experimental Medicine Affiliated Hospital of Jiangsu University">(2);

    Department of Pulmonary Medicine Affiliated Hospital of Jiangsu University">(1);

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Chemotherapy; D-dimer; Non-small cell lung cancer; Prediction; Prognosis;

    机译:化学疗法D-二聚体非小细胞肺癌;预测;预后;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号